Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Iris A. Halfpenny
Observed names:
I Halfpenny,
I. A. Halfpenny,
I. Halfpenny,
Iris A Halfpenny,
Iris Halfpenny
Institution:
Almac (United Kingdom)
Observed institutions:
University of Ulster,
Edinburgh Cancer Research,
Belfast City Hospital,
Almac (United Kingdom),
University of Edinburgh
OpenAlex ID:
A5089494651
Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.
2014
·
Charlie Gourley
, Andrena McCavigan
, et al.
·
Journal of Clinical Oncology
·
119
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling
2015
·
Joseph M Foster
, Assa Oumie
, et al.
·
BMC Medical Genomics
·
93
PDF
The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated
2004
·
Natalia Gómez‐Lozano
, Ernesto Estefanía
, et al.
·
European Journal of Immunology
·
75
PDF
KIR genes
2005
·
Derek Middleton
, Fionnuala Williams
, et al.
·
Transplant Immunology
·
69
Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals
2003
·
Fionnuala Williams
, Lynn D Maxwell
, et al.
·
Human Immunology
·
48
Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1
2004
·
Iris A. Halfpenny
, Derek Middleton
, et al.
·
Human Immunology
·
39
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours
2007
·
D. Middleton
, J. R. Vilchez
, et al.
·
Tissue Antigens
·
36
Investigation of KIR Gene Frequencies in Type 1 Diabetes Mellitus
2006
·
Derek Middleton
, Iris Halfpenny
, et al.
·
Human Immunology
·
27
Investigation of killer cell immunoglobulin‐like receptor gene diversity V. KIR3DL2
2004
·
A. Meenagh
, F. Williams
, et al.
·
Tissue Antigens
·
23
Identification of molecular subtypes within a formalin-fixed, paraffin-embedded breast cancer tumour cohort
2010
·
JM Mulligan
, F McDyer
, et al.
·
Breast Cancer Research
·
1
PDF
Investigation of KIR gene associations within two disease groups—Type I diabetes and psoriasis
2004
·
Fionnuala Williams
, Iris Halfpenny
, et al.
·
Human Immunology
·
1
Abstract LB-048: Copy number and loss of heterozygosity (LOH) analysis in 52 breast cancer FFPE samples using molecular Inversion probe array: detailed analysis of reproducibility and performance compared to NGS platforms
2015
·
Candice L. Horn
, Fabio Nunes
, et al.
·
Cancer Research
Identification of a novel breast cancer molecular subgroup associated with a deficiency in DNA-damage response.
2011
·
J. M. Mulligan
, L. A. Hill
, et al.
·
Journal of Clinical Oncology
Abstract 326: Investigation of molecular subtypes within FFPE breast cancer tumors using the Breast Cancer DSA®
2011
·
Steve Deharo
, Jude M. Mulligan
, et al.
·
Cancer Research
PP128 Expression profiling of BRCA1 and BRCA2 deficient human tumours and cell-lines using a breast specific platform to identify a biomarker of DNA repair deficiency
2009
·
P. Kerr
, J. Mulligan
, et al.
·
European Journal of Cancer Supplements
Predicting response to RAD001 treatment in post-menopausal women with ER-positive breast cancer using the breast cancer DSA™ research tool (Almac).
2009
·
VS Sabine
, A McCulla
, et al.
·
Cancer Research
KIR haplotype recombination identified through PCR-SSOP allele detection
2003
·
Fionnuala Williams
, Iris Halfpenny
, et al.
·
Human Immunology
Show more works
View as search
Works count:
17
Citation count:
531
H-index:
9
I10-index:
9
Year
Topic
Type
